NT-proBNP and echocardiographic markers for LV diastolic dysfunction and LV remodelling are of prognostic value in patients with BAV for arrhythmia- and intervention-free survival and should have a more prominent role in clinical practice. This evidence concerns the gene NPPB and Arrhythmia.